Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of NAFT-500 in Tinea Pedis
NCT00750139Phase 3Completed
- Sponsor
- Merz
- Start
- Aug 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of naftifine organogel (MediQuest Therapeutics) in tinea pedis, sponsored by Merz. Started Aug 2008; status: completed.
02
Drugs
naftifine organogel (MediQuest Therapeutics)
03
Conditions
tinea pedis
Beyond the preview
Go deeper on NCT00750139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00750139.